Xoma Corp (XOMA)

Xoma (XOMA) Stock Price & Analysis


XOMA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$15.68 - $32.09
Previous Close$17
Average Volume (3M)31.17K
Market Cap
Enterprise Value$153.16M
Total Cash (Recent Filing)$44.61M
Total Debt (Recent Filing)$69.00K
Price to Earnings (P/E)-6.5
Aug 08, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.63
Shares Outstanding11,461,068
10 Day Avg. Volume38,037
30 Day Avg. Volume31,167
Standard Deviation0.18
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)452.41
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue56.29
Enterprise Value/Gross Profit36.91
Enterprise Value/Ebitda-6.31
Price Target Upside316.16% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Xoma Corp’s price range in the past 12 months?
Xoma Corp lowest stock price was $15.68 and its highest was $32.09 in the past 12 months.
    What is Xoma Corp’s market cap?
    Currently, no data Available
    When is Xoma Corp’s upcoming earnings report date?
    Xoma Corp’s upcoming earnings report date is Aug 08, 2023 which is in 68 days.
      How were Xoma Corp’s earnings last quarter?
      Xoma Corp released its earnings results on May 09, 2023. The company reported -$0.98 earnings per share for the quarter, missing the consensus estimate of -$0.495 by -$0.485.
        Is Xoma Corp overvalued?
        According to Wall Street analysts Xoma Corp’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Xoma Corp pay dividends?
          Xoma Corp does not currently pay dividends.
          What is Xoma Corp’s EPS estimate?
          Xoma Corp’s EPS estimate is -$0.53.
            How many shares outstanding does Xoma Corp have?
            Xoma Corp has 11,461,068 shares outstanding.
              What happened to Xoma Corp’s price movement after its last earnings report?
              Xoma Corp reported an EPS of -$0.98 in its last earnings report, missing expectations of -$0.495. Following the earnings report the stock price went up 0.274%.
                Which hedge fund is a major shareholder of Xoma Corp?
                Currently, no hedge funds are holding shares in XOMA


                Xoma Stock Smart Score

                The Xoma stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Xoma Corp

                XOMA Corp. engages in the discovery and development of innovative therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.


                Top 5 ETFs holding XOMA

                Currently, no data available
                Please return soon. This page is being updated.
                Up to five ETFs with an Outperform Smart Score that hold XOMA. The ETFs are listed according to market value of XOMA within the ETF


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Kala Pharmaceuticals
                vTv Therapeutics
                Palatin Technologies

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis